Depigmenting mechanism of NSAIDs on B16F1 melanoma cells

Archives of Dermatological Research

Volumn 303, Issue 3, 2011, Pages 171-180

  Sato, Kazuomi ^a   Takahashi, Hideki ^b   Toriyama, Masaru ^b  

^a TAMAGAWA UNIVERSITY   (Japan)

^b SHIZUOKA UNIVERSITY   (Japan)

Author keywords

B16F1 melanoma; Melanogenesis; Microphthalmia associated transcription factor (Mitf); Non steroidal anti inflammatory drugs (NSAIDs); Tyrosinase

Indexed keywords

ALPHA INTERMEDIN; DICLOFENAC; MEFENAMIC ACID; MELANIN; MONOPHENOL MONOOXYGENASE; NIMESULIDE; TYROSINASE RELATED PROTEIN 1; TYROSINASE RELATED PROTEIN 2;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSCRIPTION; MELANOGENESIS; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ALPHA-MSH; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MEFENAMIC ACID; MELANINS; MELANOMA, EXPERIMENTAL; MICE; MONOPHENOL MONOOXYGENASE; OXIDOREDUCTASES; PIGMENTATION DISORDERS; SKIN PIGMENTATION; SULFONAMIDES;

EID: 79955857778     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-010-1094-8     Document Type: Article

References (32)

1. Abdel-Malek Z, Scott MC, Suzuki I, Tada A, Im S, Lamoreux L, Ito S, Barsh G, Hearing VJ (2000) The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation. Pigment Cell Res 13(Suppl. 8):156-162
2. Aroca P, Solano F, Salinas C, Garcia-Borron JC, Lozano JA (1992) Regulation of the final phase of mammalian melanogenesis: the role of dopachrome tautomerase and the ratio between 5, 6-dihydroxyindole-2-carboxylic acid and 5, 6-dihydroxyindole. Eur J Biochem 208:155-163
3. Bertolotto C, Busca R, Abbe P, Bille K, Aberdam E, Ortonne JP, Ballotti R (1998) Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol 18:694-702 (Pubitemid 28063402)
4. Born G, Patrono C (2006) Antiplatelet drugs. Br J Pharmacol 147(Suppl. 1):S241-S251 (Pubitemid 43077282)
5. Busca R, Ballotti R (2000) Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res 13:60-69 (Pubitemid 30324886)
6. Butenas S, Cawthern KM, van't Veer C, DiLorenzo ME, Lock JB, Mann KG (2001) Antiplatelet agents in tissue factor-induced blood coagulation. Blood 97:2314-2322 (Pubitemid 32291477)
7. Fisher DE (2000) Microphthalmia: a signal responsive transcriptional regulator in development. Pigment Cell Res 13(Suppl. 8):145-149
8. Hearing VJ, Tsukamoto K (1991) Enzymatic control of pigmentation in mammals. FASEB J 5:2902-2909 (Pubitemid 21905830)
9. Hosomi Y, Yokose T, Hirose Y, Nakajima R, Nagai K, Nishiwaki Y, Ochiai A (2000) Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer 30:73-81
10. Jackson IJ, Chambers DM, Tsukamoto K, Copeland NG, Gilbert DJ, Jenkins NA, Hearing VJ (1992) A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. EMBO J 11:527-535
11. Jana NR (2008) NSAIDs and apoptosis. Cell Mol Life Sci 65:1295-1301
12. Jimenez M, Tsukamoto K, Hearing VJ (1991) Tyrosinases from two different loci are expressed by normal and by transformed melanocytes. J Biol Chem 266:1147-1156 (Pubitemid 21907238)
13. Kameyama K, Takemura T, Hamada Y, Sakai C, Kondoh S, Nishiyama S, Urabe K, Hearing VJ (1993) Pigment production in murine melanoma cells is regulated by tyrosinase, tyrosinase-related protein-1 (TRP-1), DOPAchrome tautomerase (TRP-2), and a melanogenic inhibitor. J Invest Dermatol 100:126-131 (Pubitemid 23053295)
14. Korner A, Pawelek J (1982) Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science 217:1163-1165 (Pubitemid 12069041)
15. Masamoto Y, Murata Y, Baba K, Shimoishi Y, Tada M, Takahata K (2004) Inhibitory effects of esculetin on melanin biosynthesis. Biol Pharm Bull 27:422-425 (Pubitemid 41685492)
16. Park HY, Perez JM, Laursen R, Hara M, Gilchrest BA (1999) Protein kinase C-β activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain. J Biol Chem 274:16470-16478
17. Piazza GA, Rahm AK, Finn TS, Fryer BH, Li H, Stoumen AL, Pamukcu R, Ahnen DJ (1997) Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res 57:2452-2459 (Pubitemid 27255906)
18. Qiao L, Hanif R, Sphicas E, Shiff SJ, Rigas B (1998) Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells. Biochem Pharmacol 55:53-64 (Pubitemid 28101985)
19. Rao CV, Reddy BS (2004) NSAIDs and chemoprevention. Curr Cancer Drug Targets 4:29-42 (Pubitemid 38332562)
20. Romeo-Graillet C, Aberdam E, Biagoli N, Massabni W, Ortonne JP, Ballotti R (1996) Ultraviolet B radiation acts through the nitric oxide and cGMP signal transduction pathway to stimulate melanogenesis in human melanocytes. J Biol Chem 271:28052-28056 (Pubitemid 26374610)
21. Saito N, Kikkawa U, Nishizuka Y (2002) The family of protein kinase C and membrane lipid mediators. J Diabetes Complications 16:4-8 (Pubitemid 34168492)
22. Sato K, Takahashi H, Iraha R, Toriyama M (2008) Down-regulation of tyrosinase expression by acetylsalicylic acid in murine B16 melanoma. Biol Pharm Bull 31:33-37
23. Sato K, Toriyama M (2009) Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma. J Dermatol Sci 53:140-145
24. Sato K, Morita M, Ichikawa C, Takahashi H, Toriyama M (2008) Depigmenting mechanisms of all-trans retinoic acid and retinol on B16 melanoma cells. Biosci Biotechnol Biochem 72:2589-2597
25. Sprits RA (2006) Meloanoblast development and associated disorders. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Oetting WS, Ortonne J-P (eds) The pigmentary system: physiology and pathophysiology, 2nd edn. Oxford, Blackwell Publishing, pp 140-154
26. Steingrimsson E, Copeland NG, Jenkins NA (2004) Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet 38:365-411 (Pubitemid 40013733)
27. Tachibana M (2000) MITF: a stream flowing for pigment cells. Pigment Cell Res 13:230-240
28. Tachibana M, Kobayashi Y, Matsushima Y (2003) Mouse models for four types of Waardenburg syndrome. Pigment Cell Res 16:448-454 (Pubitemid 37093019)
29. The Stroke Prevention in Atrial Fibrillation Investigators (1991) Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 84:527-539
30. Tomita Y, Miyamura Y, Kono M, Nakamura R, Matsunaga J (2000) Molecular bases of congenital hypopigmentary disorders in humans and oculocutaneous albinism 1 in Japan. Pigment Cell Res 13(Suppl. 8):130-134
31. Tsukamoto K, Jackson IJ, Urabe K, Montague PM, Hearing VJ (1992) A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J 11:519-526
32. Wong BC, Zhu GH, Lam SK (1999) Aspirin induced apoptosis in gastric cancer cells. Biomed Pharmacother 53:315-318